Biology Reference
In-Depth Information
[152] Jasperson LK, Bucher C, Panoskaltsis-Mortari A, et al. Indoleamine 2,3-dioxygenase is a
critical regulator of acute graft-versus-host disease lethality. Blood 2008;111(6):3257-65.
[153] Reddy P, Sun Y, Toubai T, et al. Histone deacetylase inhibition modulates indoleamine
2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host
disease in mice. J Clin Invest 2008;118(7):2562-73.
[154] Choi S, Reddy P. HDAC inhibition and graft versus host disease. Mol Med 2011;17(5-
6):404-16.
[155] Ratajczak P, Janin A, Peffault de Larour R, et al. IDO in human gut graft-versus-host
disease. Biol Blood Marrow Transplant 2012;18(1):150-5.
[156] Landfried K, Zhu W, Waldhier MC, et al. Tryptophan catabolism is associated with acute
GVHD after human allogeneic stem cell transplantation and indicates activation of indole-
amine 2,3-dioxygenase. Blood 2011;118(26):6971-4.
[157] Rodriguez PC, Ochoa AC. Arginine regulation by myeloid derived suppressor cells
and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol Rev
2008;222:180-91.
[158] Highfill SL, Rodriguez PC, Zhou Q, et al. Bone marrow myeloid-derived suppressor
cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent
mechanism that is up-regulated by interleukin-13. Blood 2010;116(25):5738-47.
[159] Reddy P. Editorial: HDAC inhibition begets more MDSCs. J Leukocyte Biol
2012;91(5):679-81.
[160] Merlin E, Goncalves-Mendes N, Hannani D, et al. Extracorporeal photochemotherapy
induces arginase 1 in patients with graft versus host disease. Transplant Immunol
2011;24(2):100-6.
[161] Gatza E, Wahl D, Opipari A, et al. Manipulating the bioenergetics of alloreactive T cells
causes their selective apoptosis and arrests graft-versus-host disease. Sci Transl Med
2011;3(67); 67ra8.
447
Search WWH ::
Custom Search